Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Revenue: 2020-2025

Historic Revenue for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to $53.8 million.

  • Tango Therapeutics' Revenue rose 363.61% to $53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year increase of 53.28%. This contributed to the annual value of $42.1 million for FY2024, which is 15.17% up from last year.
  • Latest data reveals that Tango Therapeutics reported Revenue of $53.8 million as of Q3 2025, which was up 1,591.64% from $3.2 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Revenue peaked at $53.8 million during Q3 2025, and registered a low of $3.2 million during Q2 2025.
  • In the last 3 years, Tango Therapeutics' Revenue had a median value of $6.5 million in 2024 and averaged $12.8 million.
  • Examining YoY changes over the last 5 years, Tango Therapeutics' Revenue showed a top increase of 363.61% in 2025 and a maximum decrease of 83.99% in 2025.
  • Quarterly analysis of 5 years shows Tango Therapeutics' Revenue stood at $5.7 million in 2021, then rose by 12.16% to $6.4 million in 2022, then fell by 15.29% to $5.4 million in 2023, then declined by 24.19% to $4.1 million in 2024, then soared by 363.61% to $53.8 million in 2025.
  • Its Revenue stands at $53.8 million for Q3 2025, versus $3.2 million for Q2 2025 and $5.4 million for Q1 2025.